Cargando…
Plasma Metabolomic Profiles Differentiate Patients With Dilated Cardiomyopathy and Ischemic Cardiomyopathy
Dilated cardiomyopathy (DCM) and ischemic cardiomyopathy (ICM) are common causes of heart failure (HF). Though they share similar clinical characteristics, their differential effects on cardiovascular metabolomics have yet to be elucidated. In this study, we applied a comprehensive metabolomics plat...
Autores principales: | Zhao, Junhan, Yang, Shengwen, Jing, Ran, Jin, Han, Hu, Yiran, Wang, Jing, Gu, Min, Niu, Hongxia, Zhang, Shu, Chen, Liang, Hua, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7683512/ https://www.ncbi.nlm.nih.gov/pubmed/33240942 http://dx.doi.org/10.3389/fcvm.2020.597546 |
Ejemplares similares
-
Shared Genetic Etiology of Primary Dilated Cardiomyopathy and Ischemic Dilated Cardiomyopathy
por: Sun, Yang, et al.
Publicado: (2021) -
Metabolomics Fingerprint Predicts Risk of Death in Dilated Cardiomyopathy and Heart Failure
por: Vignoli, Alessia, et al.
Publicado: (2022) -
Elevated α-hydroxybutyrate dehydrogenase is associated with in-hospital mortality in non-ischemic dilated cardiomyopathy
por: Li, Xinyi, et al.
Publicado: (2022) -
Changes in the Left Ventricular Eicosanoid Profile in Human Dilated Cardiomyopathy
por: Sosnowski, Deanna K., et al.
Publicado: (2022) -
Multi-omics integration to identify the genetic expression and protein signature of dilated and ischemic cardiomyopathy
por: Portokallidou, Konstantina, et al.
Publicado: (2023)